Publications by authors named "Daniel Stieh"

Claim this Profile
U
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial.
Valentin Voillet, Janine van Duijn, Kanika Vanshylla, One B Dintwe, Laura Pattacini, Daniel J Stieh

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.
Susan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, Wouter Willems, Daniel J Stieh

Lancet HIV· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.
Alex Luedtke, Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Daniel J Stieh

iScience· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall, Randy Burnham, Daniel J Stieh

EBioMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial.
Nina Hertoghs, Sanne Roels, Matthias Brückner, Jerald Sadoff, Barbara L Banbury, Daniel J Stieh

EBioMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Structure, and Immunogenicity of a Soluble Prefusion-stabilized EBV gB Antigen.
Ryan S McCool, Cory M Acreman, Abigail E Powell, Sofia I Picucci, Daniel J Stieh

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.
Leigh H Fisher, Erica Lazarus, Chenchen Yu, Zoe Moodie, Daniel J Stieh

PLOS Glob Public Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.
Glenda E Gray, Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B Gilbert, Daniel J Stieh

Lancet Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Lindsay N Carpp, Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall, Randy Burnham, Daniel J Stieh

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk.
Sanne Roels, Matthias Bruckner, Jerald Sadoff, Vicky Cárdenas, Chan Tang, Daniel J Stieh

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles.
George W Nelson, Janine van Duijn, Yuko Yuki, Maria G Pau, Frank Tomaka, Daniel Stieh

J Virol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption.
Thembi Mdluli, Bonnie M Slike, Daniel J Curtis, Zhanna Shubin, Ursula Tran, Daniel J Stieh

Cell Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.
Boris Julg, Kathryn E Stephenson, Frank Tomaka, Stephen R Walsh, C Sabrina Tan, Daniel J Stieh

NPJ Vaccines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Craig A Magaret, Li Li, Allan C deCamp, Morgane Rolland, Michal Juraska, Daniel J Stieh

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute quantitation of binding antibodies from clinical samples.
Chan Tang, Annemiek Verwilligen, Jerald Sadoff, Boerries Brandenburg, Eveline Sneekes-Vriese, Daniel J Stieh

NPJ Vaccines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic HIV-1 vaccination induces anti-viral CD8 T cell functionality in the phase 1/2a clinical trial APPROACH.
Janine van Duijn, Daniel Stieh, Natalia Fernandez, Deborah King, Jill Gilmour

J Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity.
Ole Lagatie, Dax Lauwers, Harvinder Singh, Fien Vanroye, Daniel J Stieh

Microbiol Spectr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Craig Magaret, Li Li, Allan deCamp, Morgane Rolland, Michal Juraska, Daniel Stieh

Res Sq· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
Daniel J Stieh, Dan H Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E Stephenson

J Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.
Youyi Fong, Adrian B McDermott, David Benkeser, Sanne Roels, Daniel J Stieh

Nat Microbiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute HIV-1 infection viremia associate with rebound upon treatment interruption.
Thembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, Daniel B Reeves, E Fabian Cardozo-Ojeda, Daniel J Stieh

Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.
Youyi Fong, Adrian B McDermott, David Benkeser, Sanne Roels, Daniel J Stieh

medRxiv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
Carolina Herrera, Sarah Harman, Yoann Aldon, Paul Rogers, Naomi Armanasco, Daniel Stieh

AIDS· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
Ramon Roozendaal, Laura Solforosi, Daniel J Stieh, Jan Serroyen, Roel Straetemans

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis